Natural Berberine-Based Chinese Herb Medicine Assembled Nanostructures with Modified Antibacterial Application
Source abstract
Abstract
The abuse of traditional antibiotics has caused a series of health problems including antimicrobial resistance, which threatens human health. Therefore, searching for broad sources of antimicrobial agents and developing multidimensional strategies to combat bacterial infections are urgent. Here, we reported two natural self-assembling modes between berberine (BBR) and flavonoid glycosides: nanoparticles (NPs) and nanofibers (NFs), which were both mainly governed by electrostatic and hydrophobic interactions. These two nanostructures exhibited different antibacterial properties from BBR. NPs showed significantly enhanced bacteriostatic activity, whereas NFs displayed a much weaker effect than BBR. The distinguishing properties can be attributed to the different spatial configurations and self-assembly processes of NPs and NFs. Flavonoid glycosides and BBR first formed a one-dimensional complex unit and subsequently self-assembled into three-dimensional nanostructures. With the hydrophilic glucuronic acid toward the outside, NPs exhibited stronger affinity to bacteria, thereby inducing the collapse of the bacteria population and the decrease in biofilm. In addition, in vitro hemolysis tests, cytotoxicity tests, and in vivo zebrafish toxicity evaluation showed that the obtained self-assemblies had good biocompatibility. This supramolecular self-assembly strategy can be applied to construct other nanoscale antibacterial drugs and thus provides weapons for the development of self-delivering drugs in bacterial infection treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Antimicrobial Peptides and Activities · RNA Interference and Gene Delivery · Bacteriophages and microbial interactions
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Chinese Academy of Sciences (CAS) Key Laboratory for Biological Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Chinese Academy of Sciences, Beijing 100190, P.R. China
Funding
Ministry of Education of the People's Republic of China · Deutsche Forschungsgemeinschaft · National Natural Science Foundation of China · China Association of Chinese Medicine · Beijing Key Laboratory for Basic and Development Research on Chinese Medicine
References (49)
Show source-provided references
1. 10.1038/nrmicro298310.1038/nrmicro2983 ↗
2. 10.3201/eid0501.99010310.3201/eid0501.990103 ↗
3. 10.1016/S0140-6736(03)12489-010.1016/S0140-6736(03)12489-0 ↗
4. 10.1038/ismej.2007.310.1038/ismej.2007.3 ↗
5. 10.1126/science.aad938210.1126/science.aad9382 ↗
6. 10.1016/j.tim.2016.06.00910.1016/j.tim.2016.06.009 ↗
7. 10.1042/EBC2016007710.1042/EBC20160077 ↗
8. 10.1016/0378-8741(96)01393-110.1016/0378-8741(96)01393-1 ↗
9. Daniel, M. Medicinal Plants: Chemistry and Properties; Science Publishers, 2006; pp 1–4.
10. 10.1021/jacs.5b1157510.1021/jacs.5b11575 ↗
11. 10.1016/j.foodchem.2014.10.04210.1016/j.foodchem.2014.10.042 ↗
12. 10.1139/m69-19010.1139/m69-190 ↗
13. 10.1080/15216540131729118310.1080/152165401317291183 ↗
14. 10.1016/j.jconrel.2011.07.00210.1016/j.jconrel.2011.07.002 ↗
15. 10.1016/j.tibtech.2012.06.00410.1016/j.tibtech.2012.06.004 ↗
16. 10.1039/C7CS00807D10.1039/C7CS00807D ↗
17. 10.1021/nn500110a10.1021/nn500110a ↗
18. 10.1021/acsnano.7b0910910.1021/acsnano.7b09109 ↗
19. 10.1002/smll.20040013010.1002/smll.200400130 ↗
20. 10.1016/j.addr.2007.11.00710.1016/j.addr.2007.11.007 ↗
21. 10.1126/science.109583310.1126/science.1095833 ↗
22. 10.1002/ange.20130255710.1002/ange.201302557 ↗
23. 10.1186/1754-1611-3-910.1186/1754-1611-3-9 ↗
24. 10.1039/B918763B10.1039/B918763B ↗
25. 10.1126/science.297.5582.80710.1126/science.297.5582.807 ↗
26. 10.1021/nn504077c10.1021/nn504077c ↗
27. 10.1021/jacs.8b0455610.1021/jacs.8b04556 ↗
28. 10.1039/C7NR03129G10.1039/C7NR03129G ↗
29. 10.1021/jf202741x10.1021/jf202741x ↗
30. 10.3390/molecules19081263010.3390/molecules190812630 ↗
31. 10.1128/AAC.04794-1410.1128/AAC.04794-14 ↗
32. 10.1016/S0016-5085(18)32304-710.1016/S0016-5085(18)32304-7 ↗
33. 10.1111/j.1574-6968.2007.01031.x10.1111/j.1574-6968.2007.01031.x ↗
34. 10.1016/j.bcp.2015.07.01210.1016/j.bcp.2015.07.012 ↗
35. 10.1039/c2nj40405b10.1039/c2nj40405b ↗
36. 10.1039/C7SM01592E10.1039/C7SM01592E ↗
37. 10.1039/C5NR00483G10.1039/C5NR00483G ↗
38. 10.1248/cpb.60.70610.1248/cpb.60.706 ↗
39. 10.1038/nprot.2016.04410.1038/nprot.2016.044 ↗
40. 10.1016/0003-2697(89)90213-310.1016/0003-2697(89)90213-3 ↗
41. 10.1021/ja036166s10.1021/ja036166s ↗
42. 10.1016/j.ejpb.2007.11.00810.1016/j.ejpb.2007.11.008 ↗
43. 10.1021/acsnano.6b0018110.1021/acsnano.6b00181 ↗
44. 10.1021/jacs.6b0483110.1021/jacs.6b04831 ↗
45. 10.1021/jacs.8b0455610.1021/jacs.8b04556 ↗
46. 10.1021/acsami.8b0877010.1021/acsami.8b08770 ↗
47. Christensen G. D. · J. Clin. Microbiol. · 1985 · 22 · 99610.1128/jcm.22.6.996-1006.1985 ↗
48. 10.1002/smll.20080171610.1002/smll.200801716 ↗
49. 10.1021/nn204671v10.1021/nn204671v ↗